|
RDX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.4856119646729E-13 |
| Normal-vs-Stage2 |
2.16339999999926E-05 |
| Normal-vs-Stage3 |
5.55111512312578E-15 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
1.286630E-01 |
| Stage1-vs-Stage3 |
2.874200E-02 |
| Stage1-vs-Stage4 |
2.27319999999143E-05 |
| Stage2-vs-Stage3 |
3.884800E-03 |
| Stage2-vs-Stage4 |
4.27480000000369E-05 |
| Stage3-vs-Stage4 |
5.960000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.89624999999971E-05 |
| Normal-vs-Asian |
4.38240554956337E-11 |
| Caucasian-vs-AfricanAmerican |
4.153400E-01 |
| Caucasian-vs-Asian |
8.431800E-01 |
| AfricanAmerican-vs-Asian |
3.625600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16049400592055E-13 |
| Normal-vs-Female |
1.6278089987054E-12 |
| Male-vs-Female |
4.336800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.41238148848788E-12 |
| Normal-vs-Age(41-60Yrs) |
9.14934794593592E-13 |
| Normal-vs-Age(61-80Yrs) |
1.72228897810101E-12 |
| Normal-vs-Age(81-100Yrs) |
2.976100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.576800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.496630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.296000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.671200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.666000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.966600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.777000E-04 |
| Classical-VS-Follicular |
1.677450E-03 |
| Classical-VS-Other |
4.289800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.8696000003704E-07 |
| Tall-VS-Other |
5.019400E-01 |
| Tall-VS-Normal |
1.77635683940025E-15 |
| Follicular-VS-Other |
9.677800E-02 |
| Follicular-VS-Normal |
4.39869999999676E-05 |
| Other-VS-Normal |
1.823980E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39919195621496E-12 |
| Normal-vs-N1 |
4.44089209850063E-15 |
| N0-vs-N1 |
3.022800E-03 |
|
|
